|1.||Hornebeck, William: 5 articles (07/2007 - 06/2002)|
|2.||Bellon, Georges: 5 articles (07/2007 - 06/2002)|
|3.||Antonicelli, Frank: 4 articles (05/2013 - 02/2004)|
|4.||Robinet, Arnaud: 2 articles (07/2007 - 07/2005)|
|5.||Lebargy, François: 1 article (05/2013)|
|6.||Guenounou, Moncef: 1 article (05/2013)|
|7.||Gafa, Valérie: 1 article (05/2013)|
|8.||Dury, Sandra: 1 article (05/2013)|
|9.||Deslée, Gaëtan: 1 article (05/2013)|
|10.||Dupont, Aurélie: 1 article (05/2013)|
|1.||Melanoma (Melanoma, Malignant)
07/01/2005 - "We propose that S-Gal might constitute a novel therapeutic target for controlling melanoma progression."
02/01/2004 - "Upregulation of MMP-2 activation by ED led to enhanced melanoma cells invasion through S-Gal occupancy. "
02/01/2004 - "Immunohistochemistry studies, confirmed that S-Gal expression was more prominent at the melanoma invasion site associated with a strong expression of MMP-2 and MT1-MMP. "
02/01/2004 - "We hypothesize that ED following interactions with S-Gal elastin receptor can favor melanoma cells invasion through a three-dimensional type I collagen matrix by upregulating MMP-2 activation."
02/01/2004 - "The effects of ED on melanoma cells were found to be mediated by splicing form of beta-galactosidase (S-Gal) occupancy, as being suppressed by lactose. "
|2.||Chronic Obstructive Pulmonary Disease (COPD)
05/01/2013 - "The study demonstrates that the response of neutrophils from patients with COPD to VGVAPG varied according to COPD phase and critical level of S-Gal expression. "
05/01/2013 - "These findings were associated with a decreased or almost complete loss of S-Gal elastin receptor expression in neutrophils from patients with stable or exacerbated COPD, respectively. "
|3.||Mucopolysaccharidosis IV (Morquio Syndrome)
07/01/2000 - "The present study provides a novel and natural model validating functional roles of S-Gal in elastogenesis and elucidates an association between impaired elastogenesis and the development of connective-tissue disorders in patients with Morquio B disease and in patients with an infantile form of GM1-gangliosidosis."
01/01/2007 - "Importantly, binding of elastokines to S-Gal, their cognate receptor, proved to stimulate matrix metalloproteinase expression in normal and cancer cells. "
07/01/2010 - "Upon direct injection of a mixture of 3,4-cyclohexenoesculetin beta-D-galactopyranoside and ferric ammonium citrate, intense contrast was observed immediately in MCF7-lacZ tumors, but not in wild-type tumors. "
06/01/2002 - "This is due to the fact that elastin-ligation of S-gal/EBP induces motogenic, as well as mitogenic signals and releases various elastases from cancer cells and the induction depends on the metastatic potential. "
06/01/2002 - "At the opposite, a particular module in elastin (VGVAPG) with type VIII beta turn conformation stimulates MT1-MMP and proMMP-2 activation through binding to S-gal elastin receptor, and increases the matrix invasive capacity of several cancer cell lines and endothelial cells. "
|1.||Matrix Metalloproteinase 14 (MT1-MMP)
|4.||Collagen Type I (Type I Collagen)
|9.||ferric ammonium citrate